Neurocrine Bioscience buy StockNews.com
Start price
20.07.24
/
50%
€134.65
Target price
20.07.25
-
Performance (%)
-16.26%
End price
21.07.25
€112.75
Summary
This prediction ended on 21.07.25 with a price of €112.75. The prediction for Neurocrine Bioscience disappointed with a performance of -16.26%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -1.577% | -1.577% | 8.571% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.75
04.08.24
04.08.24
-
04.08.25
04.08.25
-21.11%
05.08.25
05.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.45
27.07.24
27.07.24
-
27.07.25
27.07.25
-16.98%
28.07.25
28.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€125.00
21.06.24
21.06.24
-
21.06.25
21.06.25
-11.16%
22.06.25
22.06.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24